Herzliya, Israel and Calgary, Alberta--(Newsfile Corp. - December 3, 2020) - Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (the "Company" or "Innocan"), is pleased to announce that it was invited by one of the leading IR agencies in the U.S., Lytham Partners, to participate in its End of Year 1x1 Conference (the "Conference") from December...